Who are Magnesium Citrate Oral Liquid Product's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Pizensy, Miralax, Cephulac, Milk of Magnesia, Sodium picosulfate + magnesium citrate, Macrogol 3350 and electrolytes.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/magnesium-citrate-oral-liquid-product.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Magnesium Citrate Oral Liquid Product — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Magnesium Citrate Oral Liquid Product (Magnesium Citrate Oral Liquid Product) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic laxative. Area: Gastroenterology.

marketed Osmotic laxative Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Magnesium Citrate Oral Liquid Product (Magnesium Citrate Oral Liquid Product) — Tufts Medical Center. Magnesium citrate draws water into the intestinal lumen osmotically to promote bowel evacuation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Magnesium Citrate Oral Liquid Product TARGET	Magnesium Citrate Oral Liquid Product	Tufts Medical Center	marketed	Osmotic laxative
Pizensy	LACTITOL	Braintree Labs	marketed	Osmotic Laxative		2020-01-01
Miralax	Macrogol	Braintree	marketed	Osmotic Laxative [EPC]		1984-01-01
Cephulac	LACTULOSE	Sanwa Kagaku Kenkyusho Co., Ltd.	marketed	Osmotic Laxative [EPC]		1976-01-01
Milk of Magnesia	magnesium hydroxide	Generic (multiple manufacturers)	marketed	Osmotic laxative, Antacid	Gastric acid (direct neutralization) + osmotic effect in intestine	1880-01-01
Sodium picosulfate + magnesium citrate	Sodium picosulfate + magnesium citrate	Parc de Salut Mar	marketed	Stimulant laxative + osmotic laxative combination
Macrogol 3350 and electrolytes	Macrogol 3350 and electrolytes	Odense University Hospital	marketed	Osmotic laxative

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2032-03-09 — Miralax · 10780112 · US
2032-03-09 — Miralax · 11529368 · US
2032-03-09 — Miralax · 10792306 · US
2032-03-25 — Miralax · 10646512 · US
2032-08-11 — Miralax · 9592252 · US
2033-09-10 — Miralax · 9326969 · US
2033-09-10 — Miralax · 9707297 · US
2033-09-10 — Miralax · 8999313 · US
2033-09-10 — Miralax · 10918723 · US
2033-09-10 — Miralax · 10016504 · US

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Magnesium Citrate Oral Liquid Product — Competitive Intelligence Brief. https://druglandscape.com/ci/magnesium-citrate-oral-liquid-product. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab